University of Tasmania
Browse

File(s) under permanent embargo

An exploratory examination of the mechanisms through which pre-quit patch use aids smoking cessation

journal contribution
posted on 2023-05-17, 21:20 authored by Schuz, N, Stuart FergusonStuart Ferguson

Rationale and objectives: Patches are traditionally started on the day a quit attempt begins. Recently, a number of studies have established that the patch’s effectiveness is improved by starting the treatment before quitting [pre-quit patch (PQP) use]. In an exploratory study, we investigate a proposed mechanism through which PQP use might promote abstinence: that PQP reduces satisfaction with smoking (either directly or via craving), which in turn leads to reduction and that smoking reduction promotes abstinence.

Methods: Fifty-seven interested quitters used handheld computers to monitor their smoking satisfaction, withdrawal and smoking in real time for 17 days, leading up to a quit attempt. All participants received 21 mg/24 h patches for 2 weeks before and for up to 10 weeks after quitting. Carbon dioxide (CO)-verified 28-day abstinence was assessed.

Results: During PQP treatment, participants reported significant reductions in both the satisfaction gained from smoking (p = 0.001) and their daily cigarette consumption (p = 0.001). Craving did not decrease; however, there was an interaction between time and nicotine dependence; craving decreased only among low dependent participants. Multilevel structural equation modelling revealed a direct effect of satisfaction on smoking rate. Craving did not mediate this relationship. Smoking reduction during the PQP treatment phase was not significantly associated with abstinence.

Conclusions

: The real-time data collection protocol utilised allowed for a fine-grained examination of smoking during PQP treatment. The results suggest that the reduction in daily cigarette smoking typically observed during PQP treatment is due to reductions in satisfaction with smoking. Unlike previous studies, however, smoking reduction was not significantly related to later abstinence, even though the odds ratio was comparably. Potential clinical implications of these findings are discussed.

Funding

Cancer Council of Tasmania

History

Publication title

Psychopharmacology

Volume

231

Issue

13

Pagination

2603-2609

ISSN

1432-2072

Department/School

Tasmanian School of Medicine

Publisher

Springer

Place of publication

Germany

Rights statement

Copyright 2014 Springer-Verlag Berlin Heidelberg

Repository Status

  • Restricted

Socio-economic Objectives

Public health (excl. specific population health) not elsewhere classified

Usage metrics

    University Of Tasmania

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC